End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
49.06 CNY | +2.08% |
|
+10.62% | +47.55% |
Jul. 16 | Haisco Pharmaceutical Receives US FDA Approval for Autoimmune Drug Trials | MT |
Jul. 07 | Haisco Pharmaceutical to Raise 1.37 Billion Yuan via Share Placement; Shares Slump 5% | MT |
Main competitors
Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Capi.($) | ||
---|---|---|---|---|---|---|---|---|---|
0.14% | 0.09% | 96.83x | 11.74x | - | - | - | 7.58B | ||
0.77% | 0.86% | 36.13x | 26.62x | 11.98x | 27.23x | 29.39x | 693B | ||
3.15% | 3.25% | 14.63x | 5.17x | 4.31x | 11.78x | 13.12x | 394B | ||
3.45% | 3.63% | 27.14x | 54.04x | 6.49x | 13.73x | 14.17x | 334B | ||
3.18% | 3.66% | 15.94x | 8.98x | 5.78x | 11.57x | 12.78x | 287B | ||
3.82% | 3.91% | 14.37x | 5.44x | 3.52x | 8.72x | 10.02x | 259B | ||
3.49% | 3.57% | 16.56x | 5.05x | 4.4x | 10.31x | 11.5x | 223B | ||
2.32% | 2.44% | 21.78x | 4.74x | 4.08x | 12x | 12.73x | 215B | ||
4.02% | 4.22% | 10.26x | 3.62x | 3.33x | 7.2x | 8.02x | 201B | ||
3.25% | 3.42% | 22.54x | 18.04x | 5.77x | 11.13x | 13.09x | 158B | ||
6.98% | 7.12% | 11.38x | 1.53x | 2.85x | 6.98x | 8.22x | 139B | ||
3% | 3.14% | 19.88x | 6.02x | 5.1x | 9.33x | 11.23x | 135B | ||
-.--% | -.--% | 30.62x | 6.08x | 9.11x | 19.37x | 20.25x | 118B | ||
4.97% | 5.21% | 11.75x | 1.3x | 2.48x | 8.04x | 8.86x | 118B | ||
5.23% | 5.41% | 10.94x | 4.66x | 2.8x | 7.63x | 8.15x | 96.38B | ||
3.6% | 1.73% | 26.44x | 5.76x | 8.79x | 17.31x | 18.1x | 77.65B | ||
4.83% | 5.13% | 9.56x | 3.7x | 2.14x | 6.35x | 7.19x | 73.24B | ||
0.4% | 0.45% | 50.99x | 6.87x | 11.27x | 41.15x | 44.56x | 54.58B | ||
4.61% | 4.7% | 27.92x | 1x | 2.33x | 8.59x | 21.68x | 46.18B | ||
Average | 3.22% | 3.26% | 25.04x | 9.49x | 5.36x | 13.25x | 15.17x | 191.07B | |
Weighted average by Cap. | 2.97% | 3.08% | 22.05x | 14.28x | 6.20x | 14.47x | 15.94x |
Select your edition
All financial news and data tailored to specific country editions